Sunshine Biopharma gets Canadian approval for enalapril
Sunshine Biopharma (SBFM) says it received Canadian regulatory approval for enalapril, positioning the company to expand within a stated $25.94 billion global anti-hypertensive drug market.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.